Axogen (AXGN) Total Current Liabilities (2010 - 2026)
Axogen's (AXGN) quarterly Total Current Liabilities came in at $26.0 million in Q1 2026, up 19.63% year-on-year from $21.7 million in Q1 2025, and up 10.43% quarter-over-quarter from $23.6 million in Q4 2025.
Axogen (AXGN) Total Current Liabilities (2010 - 2026) Analysis & Trends
Axogen's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $26.0 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 19.63% year-over-year to $26.0 million in Q1 2026; TTM through Mar 2026 was $26.0 million, a 19.63% increase from a year earlier, with the FY2025 full-year figure at $23.6 million, down 23.04% from the prior year.
- Total Current Liabilities rose to $26.0 million in Q1 2026 per AXGN's latest filing, from $23.6 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $30.6 million in Q4 2024 and bottomed at $21.2 million in Q1 2023.
- The 5-year median for Total Current Liabilities is $23.6 million (2022), against an average of $24.7 million.
- Across the five-year window, Total Current Liabilities advanced 28.11% in 2023 and retreated 23.04% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $23.8 million in 2022, then climbed by 28.11% to $30.4 million in 2023, then climbed by 0.59% to $30.6 million in 2024, then dropped by 23.04% to $23.6 million in 2025, then climbed by 10.43% to $26.0 million in 2026.
- Per Business Quant, the three latest AXGN Total Current Liabilities figures stand at $26.0 million (Q1 2026), $23.6 million (Q4 2025), and $28.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | 26.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.01 Mn |
| Dec 31, 2025 | 23.56 Mn |
| Sep 30, 2025 | 28.01 Mn |
| Jun 30, 2025 | 24.98 Mn |
| Mar 31, 2025 | 21.75 Mn |
| Dec 31, 2024 | 30.61 Mn |
| Sep 30, 2024 | 23.03 Mn |
| Jun 30, 2024 | 23.42 Mn |
| Mar 31, 2024 | 22.93 Mn |
| Dec 31, 2023 | 30.43 Mn |
| Sep 30, 2023 | 26.65 Mn |
| Jun 30, 2023 | 23.93 Mn |
| Mar 31, 2023 | 21.24 Mn |
| Dec 31, 2022 | 23.75 Mn |
| Sep 30, 2022 | 23.55 Mn |
| Jun 30, 2022 | 23.60 Mn |
| Mar 31, 2022 | 22.95 Mn |
| Dec 31, 2021 | 24.29 Mn |
| Sep 30, 2021 | 23.36 Mn |
| Jun 30, 2021 | 21.63 Mn |